.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Chubb
Fish and Richardson
McKesson
Chinese Patent Office
Federal Trade Commission
Dow
Daiichi Sankyo
US Army

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020409

« Back to Dashboard

NDA 020409 describes NASAREL, which is a drug marketed by Teva Branded Pharm and is included in one NDA. Additional details are available on the NASAREL profile page.

The generic ingredient in NASAREL is flunisolide. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

Summary for 020409

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.029MG/SPRAY
Approval Date:Mar 8, 1995TE:RLD:No

Expired Orange Book Patents for NDA: 020409

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded PharmNASARELflunisolideSPRAY, METERED;NASAL020409-001Mar 8, 1995► Subscribe► Subscribe
Teva Branded PharmNASARELflunisolideSPRAY, METERED;NASAL020409-001Mar 8, 1995► Subscribe► Subscribe
Teva Branded PharmNASARELflunisolideSPRAY, METERED;NASAL020409-001Mar 8, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
AstraZeneca
Colorcon
McKesson
Medtronic
US Department of Justice
Cerilliant
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot